RVTY Revvity

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Health science solutions provider across two segments (Life Sciences and Diagnostics), serving drug discovery through clinical diagnostics in 160+ countries
• • Notable new products in FY2025: Phenologic.AI™ deep-learning imaging module, EnVision Nexus® plate reader, NeoLSD™ 7 Plex MS/MS kit (first IVD for 7 lysosomal disorders from single blood spot), and T-SPOT.Flex™ customizable ELISPOT kit

Management Discussion & Analysis

• • Revenue $2,856.1M in FY2025, up $101.1M (+4%) YoY; Diagnostics +5% ($68.5M), Life Sciences +2% ($32.5M)
• • Gross margin 54.8% vs 55.8%; operating margin decreased 10 bps; SG&A ratio 34.7% vs 36.1%

Risk Factors

• • Tariffs imposed in fiscal year 2025 increased cost of revenue by ~$25M and reduced gross margin by ~$20M, primarily on European-manufactured products sold in U.S.
• • U.S. government funding uncertainty causing cautious customer spending on instrumentation and consumables across pharma, biotech, and academic segments

Management Discussion & Analysis

• • Revenue $698.9M for Q3 FY25, up 2% YoY from $684.0M; Life Sciences up 1% to $342.8M, Diagnostics up 3% to $356.1M
• • Gross margin 53.6% for Q3 FY25, down 2.66 pts YoY from 56.3%, cost of revenue 46.4% vs 43.7% YoY due to tariffs and FX impact

Risk Factors

• • New risk: Increased customer spending caution due to recent U.S. funding and regulatory uncertainties undermining purchase timing and volumes
• • Updated risk: More costly or less effective risk mitigation due to recent market developments affecting hedging and insurance strategies

What are the latest RVTY SEC filings in 2026?

Revvity (RVTY) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 4, 2025, an 8-K current report on May 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did RVTY file its most recent 10-K annual report?

Revvity (RVTY) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view RVTY 10-Q quarterly reports?

Revvity (RVTY)'s most recent 10-Q quarterly report was filed on November 4, 2025. SignalX displays every RVTY 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has RVTY filed recently?

Revvity (RVTY)'s most recent 8-K was filed on May 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find RVTY insider trading activity (Form 4)?

SignalX aggregates every RVTY Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does RVTY file with the SEC?

Revvity (RVTY) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new RVTY filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Revvity (RVTY).

What is RVTY's SEC CIK number?

Revvity (RVTY)'s SEC CIK (Central Index Key) number is 31791. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 31791 to look up all RVTY filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find RVTY return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Revvity (RVTY) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.